Investor Relations
| Biodel Inc. is a specialty pharmaceutical company that develops novel formulations of already approved therapeutics to treat endocrine disorders such as diabetes and osteoporosis. Biodel's products are created by utilizing the company's proprietary VIAdel™ technology, which enables rapid delivery of drugs into the blood through various routes of administration. Faster onset of action and non-invasive routes of delivery improve the efficacy, safety, compliance and convenience for patients. |
| NASD: BIOD |
| Aug 27, 2008 |
| 4:13 PM ET |
$17.14
+ 0.17
|
|
|
Print Page
Email Page